Regulation of NKG2D signaling during the epithelial-to-mesenchymal transition

OncoImmunology

Volumn 2, Issue 9, 2013, Pages

  López Soto, Alejandro ^a   Zapico, Leticia Huergo ^a   Acebes Huerta, Andrea ^a   Rodrigo, Luis ^b   Gonzalez, Segundo ^a  

^a DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^b HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

Colorectal carcinoma; Epithelial to mesenchymal transition; MICA B; NK cells; NKG2D; ULBP

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL KILLER CELL RECEPTOR NKG2D; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3; TRANSFORMING GROWTH FACTOR BETA; UVOMORULIN;

ANTIGEN EXPRESSION; ARTICLE; CANCER CELL; CANCER CELL CULTURE; ENZYME INHIBITION; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; IMMUNE EVASION; IMMUNE RESPONSE; IMMUNOSURVEILLANCE; METASTASIS POTENTIAL; MOLECULAR RECOGNITION; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; ONCOGENE NEU; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE;

EID: 84890280165     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.25820     Document Type: Article

References (10)

1. López-Larrea C, Suárez-Alvarez B, López-Soto A, López-Vázquez A, Gonzalez S. The NKG2D receptor: sensing stressed cells. Trends Mol Med 2008; 14:179-89; PMID:18353724; http://dx.doi.org/10.1016/j. molmed.2008.02.004
2. González S, López-Soto A, Suarez-Alvarez B, López-Vázquez A, López-Larrea C. NKG2D ligands: key targets of the immune response. Trends Immunol 2008; 29:397-403; PMID:18602338; http://dx.doi. org/10.1016/j.it.2008.04.007
3. López-Soto A, Huergo-Zapico L, Galván JA, Rodrigo L, de Herreros AG, Astudillo A, et al. Epithelialmesenchymal transition induces an antitumor immune response mediated by NKG2D receptor. J Immunol 2013; 190:4408-19; PMID:23509364; http://dx.doi. org/10.4049/jimmunol.1202950
4. López-Soto A, Folgueras AR, Seto E, Gonzalez S. HDAC3 represses the expression of NKG2D ligands ULBPs in epithelial tumour cells: potential implications for the immunosurveillance of cancer. Oncogene 2009; 28:2370-82; PMID:19430493; http://dx.doi. org/10.1038/onc.2009.117
5. Polyak K, Weinberg RA. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 2009; 9:265-73; PMID:19262571; http://dx.doi.org/10.1038/nrc2620
6. López-Soto A, Quiñones-Lombraña A, López-Arbesú R, López-Larrea C, González S. Transcriptional regulation of ULBP1, a human ligand of the NKG2D receptor. J Biol Chem 2006; 281:30419-30; PMID:16901903; http://dx.doi.org/10.1074/jbc.M604868200
7. Rodríguez-Rodero S, González S, Rodrigo L, Fernández-Morera JL, Martínez-Borra J, López-Vázquez A, et al. Transcriptional regulation of MICA and MICB: a novel polymorphism in MICB promoter alters transcriptional regulation by Sp1. Eur J Immunol 2007; 37:1938-53; PMID:17557375; http://dx.doi. org/10.1002/eji.200737031
8. Kmieciak M, Knutson KL, Dumur CI, Manjili MH. HER-2/neu antigen loss and relapse of mammary carcinoma are actively induced by T cell-mediated anti-tumor immune responses. Eur J Immunol 2007; 37:675-85; PMID:17304628; http://dx.doi. org/10.1002/eji.200636639
9. Kaiser BK, Yim D, Chow IT, Gonzalez S, Dai Z, Mann HH, et al. Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands. Nature 2007; 447:482-6; PMID:17495932; http://dx.doi. org/10.1038/nature05768
10. Ito M, Maruyama T, Saito N, Koganei S, Yamamoto K, Matsumoto N. Killer cell lectin-like receptor G1 binds three members of the classical cadherin family to inhibit NK cell cytotoxicity. J Exp Med 2006; 203:289-95; PMID:16461340; http://dx.doi.org/10.1084/ jem.20051986